AAPL341.15+1.65 (+0.49%) ▲|ABBV286.36-2.60 (-0.90%) ▼|ABT99.16-3.29 (-3.21%) ▼|ACN239.63+0.51 (+0.21%) ▲|ADBE256.33-0.40 (-0.16%) ▼|AMAT407.98+3.00 (+0.74%) ▲|AMD542.98+8.24 (+1.54%) ▲|AMGN436.48-2.46 (-0.56%) ▼|AMT179.77-3.79 (-2.06%) ▼|AMZN260.04-2.59 (-0.99%) ▼|AVGO333.80-0.57 (-0.17%) ▼|AXP321.75+3.41 (+1.07%) ▲|BA191.87+1.40 (+0.74%) ▲|BAC50.73+0.09 (+0.18%) ▲|BKNG157.99-5.93 (-3.62%) ▼|BLK1,132.51+3.83 (+0.34%) ▲|BMY61.25-0.44 (-0.71%) ▼|BNY145.28+1.03 (+0.71%) ▲|BRK-B541.72+1.90 (+0.35%) ▲|C122.60+0.09 (+0.07%) ▲|CAT734.01+8.77 (+1.21%) ▲|CL93.58-0.96 (-1.02%) ▼|CMCSA21.80-0.57 (-2.53%) ▼|COF209.72+8.16 (+4.05%) ▲|COP146.24+0.29 (+0.20%) ▲|COST990.15-4.46 (-0.45%) ▼|CRM241.54-0.90 (-0.37%) ▼|CSCO107.36+0.65 (+0.60%) ▲|CVS94.10-0.66 (-0.69%) ▼|CVX226.91+1.20 (+0.53%) ▲|DE628.79-3.41 (-0.54%) ▼|DHR228.90+4.66 (+2.08%) ▲|DIS110.58-1.09 (-0.98%) ▼|DUK121.17-0.16 (-0.13%) ▼|EMR161.89+1.43 (+0.89%) ▲|FDX298.94+0.18 (+0.06%) ▲|GD345.69+1.25 (+0.36%) ▲|GE304.97+5.10 (+1.70%) ▲|GEV921.39+31.06 (+3.49%) ▲|GILD152.75-3.76 (-2.40%) ▼|GM75.77-1.32 (-1.71%) ▼|GOOG327.00-9.40 (-2.79%) ▼|GOOGL331.07-9.21 (-2.71%) ▼|GS891.05+6.24 (+0.70%) ▲|HD313.58-1.53 (-0.48%) ▼|HON214.76+1.44 (+0.67%) ▲|IBM244.12+2.20 (+0.91%) ▲|INTC91.80+0.11 (+0.11%) ▲|INTU333.34-1.96 (-0.58%) ▼|ISRG418.37-19.63 (-4.48%) ▼|JNJ255.38-3.99 (-1.54%) ▼|JPM333.44-1.82 (-0.54%) ▼|KO92.86-0.64 (-0.68%) ▼|LIN500.09-1.80 (-0.36%) ▼|LLY1,266.98-16.68 (-1.30%) ▼|LMT548.71+0.00 (+0.00%) ▲|LOW195.92-1.36 (-0.69%) ▼|LRCX265.10+1.65 (+0.63%) ▲|MA621.11+0.69 (+0.11%) ▲|MCD244.10-2.42 (-0.98%) ▼|MDLZ63.16-0.83 (-1.30%) ▼|MDT93.77-0.87 (-0.91%) ▼|META704.66+10.41 (+1.50%) ▲|MMM170.67-0.70 (-0.41%) ▼|MO74.12-0.53 (-0.70%) ▼|MRK148.65+0.35 (+0.24%) ▲|MS181.69+1.29 (+0.72%) ▲|MSFT529.51-2.36 (-0.44%) ▼|MU904.87+8.80 (+0.98%) ▲|NEE78.56-0.30 (-0.38%) ▼|NFLX65.92-2.77 (-4.03%) ▼|NKE37.57-0.32 (-0.83%) ▼|NOW151.90+2.36 (+1.57%) ▲|NVDA218.12+1.65 (+0.76%) ▲|ORCL129.46-1.68 (-1.28%) ▼|PEP134.35+0.33 (+0.25%) ▲|PFE29.88-0.24 (-0.78%) ▼|PG157.97-1.35 (-0.85%) ▼|PLTR196.90+4.30 (+2.23%) ▲|PM196.25-3.66 (-1.83%) ▼|QCOM176.25+0.54 (+0.31%) ▲|RTX191.35-1.99 (-1.03%) ▼|SBUX98.62-0.75 (-0.75%) ▼|SCHW91.23+0.34 (+0.37%) ▲|SO90.40-0.32 (-0.35%) ▼|SPG205.54-1.46 (-0.70%) ▼|T22.01-1.41 (-6.02%) ▼|TMO690.98+3.61 (+0.53%) ▲|TMUS153.72-4.04 (-2.56%) ▼|TSLA386.41+12.70 (+3.40%) ▲|TXN282.60+4.82 (+1.73%) ▲|UBER68.42-0.52 (-0.75%) ▼|UNH417.07-2.19 (-0.52%) ▼|UNP290.03+2.42 (+0.84%) ▲|UPS99.03+0.51 (+0.51%) ▲|USB59.03-0.06 (-0.10%) ▼|V407.04+0.47 (+0.12%) ▲|VZ43.39-1.16 (-2.59%) ▼|WFC81.86-0.34 (-0.41%) ▼|WMT117.51-0.34 (-0.29%) ▼|XOM177.96+0.10 (+0.06%) ▲|AAPL341.15+1.65 (+0.49%) ▲|ABBV286.36-2.60 (-0.90%) ▼|ABT99.16-3.29 (-3.21%) ▼|ACN239.63+0.51 (+0.21%) ▲|ADBE256.33-0.40 (-0.16%) ▼|AMAT407.98+3.00 (+0.74%) ▲|AMD542.98+8.24 (+1.54%) ▲|AMGN436.48-2.46 (-0.56%) ▼|AMT179.77-3.79 (-2.06%) ▼|AMZN260.04-2.59 (-0.99%) ▼|AVGO333.80-0.57 (-0.17%) ▼|AXP321.75+3.41 (+1.07%) ▲|BA191.87+1.40 (+0.74%) ▲|BAC50.73+0.09 (+0.18%) ▲|BKNG157.99-5.93 (-3.62%) ▼|BLK1,132.51+3.83 (+0.34%) ▲|BMY61.25-0.44 (-0.71%) ▼|BNY145.28+1.03 (+0.71%) ▲|BRK-B541.72+1.90 (+0.35%) ▲|C122.60+0.09 (+0.07%) ▲|CAT734.01+8.77 (+1.21%) ▲|CL93.58-0.96 (-1.02%) ▼|CMCSA21.80-0.57 (-2.53%) ▼|COF209.72+8.16 (+4.05%) ▲|COP146.24+0.29 (+0.20%) ▲|COST990.15-4.46 (-0.45%) ▼|CRM241.54-0.90 (-0.37%) ▼|CSCO107.36+0.65 (+0.60%) ▲|CVS94.10-0.66 (-0.69%) ▼|CVX226.91+1.20 (+0.53%) ▲|DE628.79-3.41 (-0.54%) ▼|DHR228.90+4.66 (+2.08%) ▲|DIS110.58-1.09 (-0.98%) ▼|DUK121.17-0.16 (-0.13%) ▼|EMR161.89+1.43 (+0.89%) ▲|FDX298.94+0.18 (+0.06%) ▲|GD345.69+1.25 (+0.36%) ▲|GE304.97+5.10 (+1.70%) ▲|GEV921.39+31.06 (+3.49%) ▲|GILD152.75-3.76 (-2.40%) ▼|GM75.77-1.32 (-1.71%) ▼|GOOG327.00-9.40 (-2.79%) ▼|GOOGL331.07-9.21 (-2.71%) ▼|GS891.05+6.24 (+0.70%) ▲|HD313.58-1.53 (-0.48%) ▼|HON214.76+1.44 (+0.67%) ▲|IBM244.12+2.20 (+0.91%) ▲|INTC91.80+0.11 (+0.11%) ▲|INTU333.34-1.96 (-0.58%) ▼|ISRG418.37-19.63 (-4.48%) ▼|JNJ255.38-3.99 (-1.54%) ▼|JPM333.44-1.82 (-0.54%) ▼|KO92.86-0.64 (-0.68%) ▼|LIN500.09-1.80 (-0.36%) ▼|LLY1,266.98-16.68 (-1.30%) ▼|LMT548.71+0.00 (+0.00%) ▲|LOW195.92-1.36 (-0.69%) ▼|LRCX265.10+1.65 (+0.63%) ▲|MA621.11+0.69 (+0.11%) ▲|MCD244.10-2.42 (-0.98%) ▼|MDLZ63.16-0.83 (-1.30%) ▼|MDT93.77-0.87 (-0.91%) ▼|META704.66+10.41 (+1.50%) ▲|MMM170.67-0.70 (-0.41%) ▼|MO74.12-0.53 (-0.70%) ▼|MRK148.65+0.35 (+0.24%) ▲|MS181.69+1.29 (+0.72%) ▲|MSFT529.51-2.36 (-0.44%) ▼|MU904.87+8.80 (+0.98%) ▲|NEE78.56-0.30 (-0.38%) ▼|NFLX65.92-2.77 (-4.03%) ▼|NKE37.57-0.32 (-0.83%) ▼|NOW151.90+2.36 (+1.57%) ▲|NVDA218.12+1.65 (+0.76%) ▲|ORCL129.46-1.68 (-1.28%) ▼|PEP134.35+0.33 (+0.25%) ▲|PFE29.88-0.24 (-0.78%) ▼|PG157.97-1.35 (-0.85%) ▼|PLTR196.90+4.30 (+2.23%) ▲|PM196.25-3.66 (-1.83%) ▼|QCOM176.25+0.54 (+0.31%) ▲|RTX191.35-1.99 (-1.03%) ▼|SBUX98.62-0.75 (-0.75%) ▼|SCHW91.23+0.34 (+0.37%) ▲|SO90.40-0.32 (-0.35%) ▼|SPG205.54-1.46 (-0.70%) ▼|T22.01-1.41 (-6.02%) ▼|TMO690.98+3.61 (+0.53%) ▲|TMUS153.72-4.04 (-2.56%) ▼|TSLA386.41+12.70 (+3.40%) ▲|TXN282.60+4.82 (+1.73%) ▲|UBER68.42-0.52 (-0.75%) ▼|UNH417.07-2.19 (-0.52%) ▼|UNP290.03+2.42 (+0.84%) ▲|UPS99.03+0.51 (+0.51%) ▲|USB59.03-0.06 (-0.10%) ▼|V407.04+0.47 (+0.12%) ▲|VZ43.39-1.16 (-2.59%) ▼|WFC81.86-0.34 (-0.41%) ▼|WMT117.51-0.34 (-0.29%) ▼|XOM177.96+0.10 (+0.06%) ▲|
10.7 C
New York
Wednesday, October 21, 2026

Tag: inflammation

newsFORsourcecompanycontentinformation1releasesmarket

Once-Weekly Drug Demonstrates Promising Dual Benefits in Obesity and Metabolic Health

Injectable Offers Potential to Reduce Fatty Liver Diseases and Improve Health Markers in AdultsNEW ORLEANS, June 7, 2026 /PRNewswire/ -- New data highlight the potential...

Lilly’s Foundayo (orforglipron), the only oral GLP-1 taken without food or water restrictions, was associated with significant weight loss in women at every stage...

In ATTAIN-1, women in perimenopause taking Foundayo lost up to 30.4 lbs (14.4%) and those in post-menopause lost up to 28.2 lbs (14.1%)In ATTAIN-2, women taking Foundayo lost significant...

Wegovy® pill prescriptions surpass 3 million, 1 filled roughly every 5 seconds, bringing GLP-1 therapy to people with obesity previously untreated, while Novo Nordisk...

Three million prescriptions for Wegovy® pill since launch on January 5th serves as another milestone in one of the strongest US pharmaceutical launches by...

Lilly’s triple agonist, retatrutide, drove substantial improvements in weight, A1C, knee osteoarthritis pain, and obstructive sleep apnea, demonstrating its remarkable potential to treat obesity...

In TRIUMPH-1, participants on retatrutide 12 mg lost an average of 70.3 lbs (28.3%) over 80 weeks, with 65.3% achieving a BMI below 30,...

Novo Nordisk to present new data on Wegovy® across a wide range of cardiometabolic conditions at the American Diabetes Association’s 2026 Scientific Sessions

Post hoc analyses explored the impact of semaglutide across an array of conditions including obstructive sleep apnea (OSA), asthma-related adverse outcomes, liver health, cardiometabolic...

Cullinan Therapeutics Presents Initial Clinical Data for CLN-978, a CD19xCD3 T Cell Engager, at the EULAR 2026 Congress

Clinical benefit, including remissions, demonstrated in both systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) patients following a single target dose of CLN-978 

Bio Preventive Medicine and Precision Diabetes Announce ADA Late-Breaking Presentation Highlighting DNlite™ in Landmark CREDENCE Trial

New analysis supports DNlite™ for earlier renal risk stratification in patients with type 2 diabetes and chronic kidney diseaseZHUBEI CITY, Taiwan and RALEIGH, N.C.,...

Altesa BioSciences Presents New Phase 2 Vapendavir Challenge Study Results at 2026 American Society for Microbiology (ASM) Microbe Conference

New clinical findings further reinforce therapeutic potential of vapendavir as targeted approach to preventing rhinovirus-driven COPD exacerbationsWASHINGTON, June 5, 2026 /PRNewswire/ -- Altesa BioSciences, a...

Informations relatives au nombre total de droits de vote et d’actions composant le capital

Informations relatives au nombre total de droits de vote et d’actions composant le capital

London Specialist Dentists Announce the Use of Ozone Therapy in Periodontal Treatment and Dental Implants

LONDON, June 04, 2026 (GLOBE NEWSWIRE) -- London Specialist Dentists has announced the use of medical-grade Ozone Therapy as part of its advanced approach to periodontal treatment, dental implant care, and minimally invasive gum therapy.

MetaVia to Highlight Novel Obesity and Metabolic Therapies at Upcoming Emerging Growth Conference

CAMBRIDGE, Mass., June 4, 2026 /PRNewswire/ -- MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that Hyung Heon...

AbolerIS Pharma Presents New Data Supporting CD45RC as a Novel Therapeutic Target and Potential Biomarker in Sjögren’s Disease at EULAR 2026

- Findings demonstrate strong correlation between CD45RC expression and lymphocytic infiltration in salivary glands, supporting its potential as both an early biomarker and therapeutic...

Annual General Meeting on June 24, 2026 Procedures for obtaining preparatory documents for the General Meeting

Assemblée Générale Mixte du 24 juin 2026 Modalités de mise à disposition des documents préparatoires à l’Assemblée

In HelloNation, Holistic Health Expert Cynde Schneider Discusses How Integrative Medicine Differs From Traditional Medical Care

LAMESA, Texas, June 3, 2026 /PRNewswire/ -- The article explores how personalized care and lifestyle-focused evaluations support long-term overall wellness. ...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsInflammation

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers